Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CTAD
CTAD
CTAD 2022 – Lexeo takes baby steps towards an Alzheimer’s gene therapy
EP Vantage
Sun, 12/4/22 - 01:07 pm
Lexeo
Alzheimer's disease
CTAD
gene therapy
CTAD 2022 – lecanemab data hold up, with a big but
EP Vantage
Thu, 12/1/22 - 07:01 pm
Biogen
Eisai
Alzheimer's disease
CTAD
lecanemab
clinical trials
CTAD 2022 – gantenerumab’s shortcomings keep amyloid hypothesis alive
EP Vantage
Thu, 12/1/22 - 10:28 am
Roche
clinical trials
CTAD
Alzheimer's disease
gantenerumab
Biogen to Present New Aduhelm Data at Upcoming Alzheimer’s Conference
BioSpace
Wed, 11/3/21 - 11:37 pm
Biogen
Aduhelm
Alzheimer's disease
CTAD